Grade My Investments

Zimmer Biomet Holdings, Inc. (ZBH) Stock Grade

ZBH · Healthcare

B-
Grade updated: August 16, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$19.5B
P/E Ratio
25.3
Revenue Growth (YoY)
+7.2%
Net Margin
8.6%
Return on Equity
5.6%
Dividend Yield
1.1%

About Zimmer Biomet Holdings, Inc.'s fundamentals

Zimmer Biomet is a medical device company with a market capitalization of $17.8 billion that generated 7.2% year-over-year revenue growth. The company operates with an 8.6% net profit margin and trades at a P/E ratio of 25.3. Its return on equity stands at 5.6%, while shareholders receive a 1.1% dividend yield.

Track ZBH free — no credit card required. Live grade + monthly AI report →